Yaqing Cao

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Yaqing Cao, Wenyi Lu, Rui Sun et al. · Frontiers in Oncology · 2019 · 152 citations · Full text

Chimeric Antigen Receptor, Lymphoid Neoplasia, Cell Therapy +15

Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation

Shuo Yang, Yunxiong Wei, Rui Sun et al. · Cytotherapy · 2020 · 40 citations

Regenerative Medicine, Cell Therapy, Transplantation +13

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease

Wenyi Lu, Yunxiong Wei, Yaqing Cao et al. · Cancer Immunology Immunotherapy · 2021 · 21 citations · Full text

Cell Therapy, Immunology, Pathology +19

The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development

Wei Zhang, Jiangfeng Mao, Xi Wang et al. · Andrology · 2023 · 13 citations · Full text

Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib

Yang Hong, Ling Zhang, Xiaopeng Tian et al. · BMC Cancer · 2021 · 12 citations · Full text